Institution
University of Alberta
Education•Edmonton, Alberta, Canada•
About: University of Alberta is a education organization based out in Edmonton, Alberta, Canada. It is known for research contribution in the topics: Population & Health care. The organization has 65403 authors who have published 154847 publications receiving 5358338 citations. The organization is also known as: Ualberta & UAlberta.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: Tests of the relative fit of several alternative models supported a single latent EF construct, and measurement invariance testing revealed less proficient EF in children at higher sociodemographic risk relative to those at lower risk and no differences between boys and girls.
617 citations
•
TL;DR: The sex difference in the QT interval is due to QT shortening in males after puberty rather than QT prolongation in women during reproductive years, and it indicates that the traditional concept of reverse sequence of ventricular repolarization is not universally valid in all myocardial regions.
616 citations
••
Libin Cardiovascular Institute of Alberta1, University of Toledo2, University of Iowa3, Mayo Clinic4, Johns Hopkins University5, University of British Columbia6, Population Health Research Institute7, New York Medical College8, National Institutes of Health9, Stanford University10, University of São Paulo11, University of Arizona12, Royal Adelaide Hospital13, Cleveland Clinic14, Children's National Medical Center15, University of Alberta16, Central Michigan University17
TL;DR: Robert S. Sheldon, Blair P. Grubb II, Brian Olshansky, Win-Kuang Shen, Hugh Calkins, Michele Brignole, Satish R. Raj, Andrew D. Krahn, Carlos A. Morillo, Julian M. Stewart, Richard Sutton, Paola Sandroni, Karen J. Friday, Denise Tessariol Hachul, Mitchell I. Lau.
616 citations
••
University of Silesia in Katowice1, South Tees Hospitals NHS Trust2, Charles University in Prague3, Aarhus University4, University of Barcelona5, Hospital Italiano de Buenos Aires6, University of Alberta7, University of Pennsylvania8, Pierre-and-Marie-Curie University9, University of Freiburg10, Eli Lilly and Company11, Scripps Research Institute12
TL;DR: Neither facilitation of PCI with reteplase plus abcximab nor facilitation with abciximab alone significantly improved the clinical outcomes, as compared with ab ciximabs given at the time of PCI, in patients with ST-segment elevation myocardial infarction.
Abstract: In this international, double-blind, placebo-controlled study, we randomly assigned patients with ST-segment elevation myocardial infarction who presented 6 hours or less after the onset of symptoms to receive combination-facilitated PCI, abciximabfacilitated PCI, or primary PCI. All patients received unfractionated heparin or enoxaparin before PCI and a 12-hour infusion of abciximab after PCI. The primary end point was the composite of death from all causes, ventricular fibrillation occurring more than 48 hours after randomization, cardiogenic shock, and congestive heart failure during the first 90 days after randomization. Results A total of 2452 patients were randomly assigned to a treatment group. Significantly more patients had early ST-segment resolution with combination-facilitated PCI (43.9%) than with abciximab-facilitated PCI (33.1%) or primary PCI (31.0%; P = 0.01 and P = 0.003, respectively). The primary end point occurred in 9.8%, 10.5%, and 10.7% of the patients in the combination-facilitated PCI group, abciximab-facilitated PCI group, and primary-PCI group, respectively (P = 0.55); 90-day mortality rates were 5.2%, 5.5%, and 4.5%, respectively (P = 0.49). Conclusions Neither facilitation of PCI with reteplase plus abciximab nor facilitation with abciximab alone significantly improved the clinical outcomes, as compared with abciximab given at the time of PCI, in patients with ST-segment elevation myocardial infarction. (ClinicalTrials.gov number, NCT00046228.)
616 citations
••
TL;DR: In this paper, the authors provided a thorough economic analysis of the simplest bottleneck model of road congestion with peak-load demand, where a fixed number of identical individuals, one per car, must travel from home to work, between which is a bottleneck of given capacity.
616 citations
Authors
Showing all 66027 results
Name | H-index | Papers | Citations |
---|---|---|---|
Salim Yusuf | 231 | 1439 | 252912 |
Yi Chen | 217 | 4342 | 293080 |
Robert M. Califf | 196 | 1561 | 167961 |
Douglas R. Green | 182 | 661 | 145944 |
Russel J. Reiter | 169 | 1646 | 121010 |
Jiawei Han | 168 | 1233 | 143427 |
Jaakko Kaprio | 163 | 1532 | 126320 |
Tobin J. Marks | 159 | 1621 | 111604 |
Josef M. Penninger | 154 | 700 | 107295 |
Subir Sarkar | 149 | 1542 | 144614 |
Gerald M. Edelman | 147 | 545 | 69091 |
Rinaldo Bellomo | 147 | 1714 | 120052 |
P. Sinervo | 138 | 1516 | 99215 |
David A. Jackson | 136 | 1095 | 68352 |
Andreas Warburton | 135 | 1578 | 97496 |